Genus (GNS) Stock Rating Reaffirmed by Liberum Capital

Liberum Capital restated their buy rating on shares of Genus (LON:GNS) in a research report report published on Friday, ThisIsMoney.Co.Uk reports.

A number of other brokerages have also recently weighed in on GNS. Peel Hunt increased their target price on shares of Genus from GBX 2,800 ($36.59) to GBX 3,200 ($41.81) and gave the stock a buy rating in a report on Thursday. HSBC began coverage on shares of Genus in a report on Tuesday, February 12th. They set a buy rating and a GBX 2,650 ($34.63) target price on the stock.

Shares of LON:GNS opened at GBX 2,836 ($37.06) on Friday. The firm has a market cap of $1.83 billion and a price-to-earnings ratio of -262.59. Genus has a 1-year low of GBX 2,090 ($27.31) and a 1-year high of GBX 2,998 ($39.17). The company has a debt-to-equity ratio of 22.58, a quick ratio of 1.32 and a current ratio of 2.08.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Article: What is Considered a Good Return on Equity (ROE)?

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.